Diet and physical exercise in psoriasis: A randomized controlled trial

L. Naldi, A. Conti, S. Cazzaniga, A. Patrizi, M. Pazzaglia, A. Lanzoni, L. Veneziano, G. Pellacani, Roberta Miglietta, Claudia Padalino, Alberto Giannetti, Silvia Santoro, Francesca Satolli, Stefano Donelli, Francesco Savoia, Vito Di Lernia, Annarosa Virgili, Alessandro Borghi, Franco Alessandrini, Raffaella Di Crecchio

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Background Increased body mass index and weight gain are risk factors for psoriasis, and the prevalence of obesity in patients with psoriasis is higher than in the general population. Limited data exist regarding the role of diet in psoriasis. Objectives To assess the impact of a dietary intervention combined with physical exercise for weight loss on improving psoriasis in overweight or obese patients. Methods This study included 303 overweight or obese patients with moderate-to-severe chronic plaque psoriasis who did not achieve clearance after 4 weeks of continuous systemic treatment. They were randomized to receive either a 20-week quantitative and qualitative dietary plan associated with physical exercise for weight loss or simple informative counselling at baseline about the utility of weight loss for clinical control of psoriatic disease. The main outcome was any reduction of the Psoriasis Area and Severity Index (PASI) from baseline to week 20. Results Intention-to-treat analysis showed a median PASI reduction of 48% (95% confidence interval 33·3-58·3%) in the dietary intervention arm and 25·5% (95% confidence interval 18·2-33·3%) in the information-only arm (P = 0·02). Among secondary outcomes, PASI score reduction of ≥ 50% significantly differed between study arms (49·7% with dietary intervention vs. 34·2% with information only, P = 0·006). The weight-loss target (a ≥ 5% reduction from baseline) was reached by 29·8% of patients in the dietary intervention arm compared with 14·5% in the information-only arm (P = 0·001). Conclusions A 20-week dietetic intervention associated with increased physical exercise reduced psoriasis severity in systemically treated overweight or obese patients with active psoriasis. What's already known about this topic? Obesity is a risk factor for psoriasis development in both adult and paediatric populations. Psoriasis is associated with metabolic derangements, such as type II diabetes. Obesity may reduce the response to systemic treatment. What does this study add? This randomized controlled trial shows that an intervention combining diet restriction and promotion of physical exercise in overweight or obese patients with active psoriasis helps to reduce psoriasis severity beyond the effects of systemic treatment over a 20-week period. The effect may be related to the weight loss alone, or to some indirect influence on patient compliance or other treatment components.

Original languageEnglish
Pages (from-to)634-642
Number of pages9
JournalBritish Journal of Dermatology
Volume170
Issue number3
DOIs
Publication statusPublished - Mar 1 2014

Fingerprint

Psoriasis
Randomized Controlled Trials
Exercise
Diet
Weight Loss
Obesity
Confidence Intervals
Intention to Treat Analysis
Dietetics
Therapeutics
Patient Compliance
Type 2 Diabetes Mellitus
Population
Weight Gain
Counseling
Body Mass Index
Pediatrics

ASJC Scopus subject areas

  • Dermatology
  • Medicine(all)

Cite this

Naldi, L., Conti, A., Cazzaniga, S., Patrizi, A., Pazzaglia, M., Lanzoni, A., ... Di Crecchio, R. (2014). Diet and physical exercise in psoriasis: A randomized controlled trial. British Journal of Dermatology, 170(3), 634-642. https://doi.org/10.1111/bjd.12735

Diet and physical exercise in psoriasis : A randomized controlled trial. / Naldi, L.; Conti, A.; Cazzaniga, S.; Patrizi, A.; Pazzaglia, M.; Lanzoni, A.; Veneziano, L.; Pellacani, G.; Miglietta, Roberta; Padalino, Claudia; Giannetti, Alberto; Santoro, Silvia; Satolli, Francesca; Donelli, Stefano; Savoia, Francesco; Di Lernia, Vito; Virgili, Annarosa; Borghi, Alessandro; Alessandrini, Franco; Di Crecchio, Raffaella.

In: British Journal of Dermatology, Vol. 170, No. 3, 01.03.2014, p. 634-642.

Research output: Contribution to journalArticle

Naldi, L, Conti, A, Cazzaniga, S, Patrizi, A, Pazzaglia, M, Lanzoni, A, Veneziano, L, Pellacani, G, Miglietta, R, Padalino, C, Giannetti, A, Santoro, S, Satolli, F, Donelli, S, Savoia, F, Di Lernia, V, Virgili, A, Borghi, A, Alessandrini, F & Di Crecchio, R 2014, 'Diet and physical exercise in psoriasis: A randomized controlled trial', British Journal of Dermatology, vol. 170, no. 3, pp. 634-642. https://doi.org/10.1111/bjd.12735
Naldi L, Conti A, Cazzaniga S, Patrizi A, Pazzaglia M, Lanzoni A et al. Diet and physical exercise in psoriasis: A randomized controlled trial. British Journal of Dermatology. 2014 Mar 1;170(3):634-642. https://doi.org/10.1111/bjd.12735
Naldi, L. ; Conti, A. ; Cazzaniga, S. ; Patrizi, A. ; Pazzaglia, M. ; Lanzoni, A. ; Veneziano, L. ; Pellacani, G. ; Miglietta, Roberta ; Padalino, Claudia ; Giannetti, Alberto ; Santoro, Silvia ; Satolli, Francesca ; Donelli, Stefano ; Savoia, Francesco ; Di Lernia, Vito ; Virgili, Annarosa ; Borghi, Alessandro ; Alessandrini, Franco ; Di Crecchio, Raffaella. / Diet and physical exercise in psoriasis : A randomized controlled trial. In: British Journal of Dermatology. 2014 ; Vol. 170, No. 3. pp. 634-642.
@article{e4548fd0c36f4aa28e0d34b4aca85cee,
title = "Diet and physical exercise in psoriasis: A randomized controlled trial",
abstract = "Background Increased body mass index and weight gain are risk factors for psoriasis, and the prevalence of obesity in patients with psoriasis is higher than in the general population. Limited data exist regarding the role of diet in psoriasis. Objectives To assess the impact of a dietary intervention combined with physical exercise for weight loss on improving psoriasis in overweight or obese patients. Methods This study included 303 overweight or obese patients with moderate-to-severe chronic plaque psoriasis who did not achieve clearance after 4 weeks of continuous systemic treatment. They were randomized to receive either a 20-week quantitative and qualitative dietary plan associated with physical exercise for weight loss or simple informative counselling at baseline about the utility of weight loss for clinical control of psoriatic disease. The main outcome was any reduction of the Psoriasis Area and Severity Index (PASI) from baseline to week 20. Results Intention-to-treat analysis showed a median PASI reduction of 48{\%} (95{\%} confidence interval 33·3-58·3{\%}) in the dietary intervention arm and 25·5{\%} (95{\%} confidence interval 18·2-33·3{\%}) in the information-only arm (P = 0·02). Among secondary outcomes, PASI score reduction of ≥ 50{\%} significantly differed between study arms (49·7{\%} with dietary intervention vs. 34·2{\%} with information only, P = 0·006). The weight-loss target (a ≥ 5{\%} reduction from baseline) was reached by 29·8{\%} of patients in the dietary intervention arm compared with 14·5{\%} in the information-only arm (P = 0·001). Conclusions A 20-week dietetic intervention associated with increased physical exercise reduced psoriasis severity in systemically treated overweight or obese patients with active psoriasis. What's already known about this topic? Obesity is a risk factor for psoriasis development in both adult and paediatric populations. Psoriasis is associated with metabolic derangements, such as type II diabetes. Obesity may reduce the response to systemic treatment. What does this study add? This randomized controlled trial shows that an intervention combining diet restriction and promotion of physical exercise in overweight or obese patients with active psoriasis helps to reduce psoriasis severity beyond the effects of systemic treatment over a 20-week period. The effect may be related to the weight loss alone, or to some indirect influence on patient compliance or other treatment components.",
author = "L. Naldi and A. Conti and S. Cazzaniga and A. Patrizi and M. Pazzaglia and A. Lanzoni and L. Veneziano and G. Pellacani and Roberta Miglietta and Claudia Padalino and Alberto Giannetti and Silvia Santoro and Francesca Satolli and Stefano Donelli and Francesco Savoia and {Di Lernia}, Vito and Annarosa Virgili and Alessandro Borghi and Franco Alessandrini and {Di Crecchio}, Raffaella",
year = "2014",
month = "3",
day = "1",
doi = "10.1111/bjd.12735",
language = "English",
volume = "170",
pages = "634--642",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Blackwell Publishing Ltd",
number = "3",

}

TY - JOUR

T1 - Diet and physical exercise in psoriasis

T2 - A randomized controlled trial

AU - Naldi, L.

AU - Conti, A.

AU - Cazzaniga, S.

AU - Patrizi, A.

AU - Pazzaglia, M.

AU - Lanzoni, A.

AU - Veneziano, L.

AU - Pellacani, G.

AU - Miglietta, Roberta

AU - Padalino, Claudia

AU - Giannetti, Alberto

AU - Santoro, Silvia

AU - Satolli, Francesca

AU - Donelli, Stefano

AU - Savoia, Francesco

AU - Di Lernia, Vito

AU - Virgili, Annarosa

AU - Borghi, Alessandro

AU - Alessandrini, Franco

AU - Di Crecchio, Raffaella

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Background Increased body mass index and weight gain are risk factors for psoriasis, and the prevalence of obesity in patients with psoriasis is higher than in the general population. Limited data exist regarding the role of diet in psoriasis. Objectives To assess the impact of a dietary intervention combined with physical exercise for weight loss on improving psoriasis in overweight or obese patients. Methods This study included 303 overweight or obese patients with moderate-to-severe chronic plaque psoriasis who did not achieve clearance after 4 weeks of continuous systemic treatment. They were randomized to receive either a 20-week quantitative and qualitative dietary plan associated with physical exercise for weight loss or simple informative counselling at baseline about the utility of weight loss for clinical control of psoriatic disease. The main outcome was any reduction of the Psoriasis Area and Severity Index (PASI) from baseline to week 20. Results Intention-to-treat analysis showed a median PASI reduction of 48% (95% confidence interval 33·3-58·3%) in the dietary intervention arm and 25·5% (95% confidence interval 18·2-33·3%) in the information-only arm (P = 0·02). Among secondary outcomes, PASI score reduction of ≥ 50% significantly differed between study arms (49·7% with dietary intervention vs. 34·2% with information only, P = 0·006). The weight-loss target (a ≥ 5% reduction from baseline) was reached by 29·8% of patients in the dietary intervention arm compared with 14·5% in the information-only arm (P = 0·001). Conclusions A 20-week dietetic intervention associated with increased physical exercise reduced psoriasis severity in systemically treated overweight or obese patients with active psoriasis. What's already known about this topic? Obesity is a risk factor for psoriasis development in both adult and paediatric populations. Psoriasis is associated with metabolic derangements, such as type II diabetes. Obesity may reduce the response to systemic treatment. What does this study add? This randomized controlled trial shows that an intervention combining diet restriction and promotion of physical exercise in overweight or obese patients with active psoriasis helps to reduce psoriasis severity beyond the effects of systemic treatment over a 20-week period. The effect may be related to the weight loss alone, or to some indirect influence on patient compliance or other treatment components.

AB - Background Increased body mass index and weight gain are risk factors for psoriasis, and the prevalence of obesity in patients with psoriasis is higher than in the general population. Limited data exist regarding the role of diet in psoriasis. Objectives To assess the impact of a dietary intervention combined with physical exercise for weight loss on improving psoriasis in overweight or obese patients. Methods This study included 303 overweight or obese patients with moderate-to-severe chronic plaque psoriasis who did not achieve clearance after 4 weeks of continuous systemic treatment. They were randomized to receive either a 20-week quantitative and qualitative dietary plan associated with physical exercise for weight loss or simple informative counselling at baseline about the utility of weight loss for clinical control of psoriatic disease. The main outcome was any reduction of the Psoriasis Area and Severity Index (PASI) from baseline to week 20. Results Intention-to-treat analysis showed a median PASI reduction of 48% (95% confidence interval 33·3-58·3%) in the dietary intervention arm and 25·5% (95% confidence interval 18·2-33·3%) in the information-only arm (P = 0·02). Among secondary outcomes, PASI score reduction of ≥ 50% significantly differed between study arms (49·7% with dietary intervention vs. 34·2% with information only, P = 0·006). The weight-loss target (a ≥ 5% reduction from baseline) was reached by 29·8% of patients in the dietary intervention arm compared with 14·5% in the information-only arm (P = 0·001). Conclusions A 20-week dietetic intervention associated with increased physical exercise reduced psoriasis severity in systemically treated overweight or obese patients with active psoriasis. What's already known about this topic? Obesity is a risk factor for psoriasis development in both adult and paediatric populations. Psoriasis is associated with metabolic derangements, such as type II diabetes. Obesity may reduce the response to systemic treatment. What does this study add? This randomized controlled trial shows that an intervention combining diet restriction and promotion of physical exercise in overweight or obese patients with active psoriasis helps to reduce psoriasis severity beyond the effects of systemic treatment over a 20-week period. The effect may be related to the weight loss alone, or to some indirect influence on patient compliance or other treatment components.

UR - http://www.scopus.com/inward/record.url?scp=84896085402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896085402&partnerID=8YFLogxK

U2 - 10.1111/bjd.12735

DO - 10.1111/bjd.12735

M3 - Article

C2 - 24641585

AN - SCOPUS:84896085402

VL - 170

SP - 634

EP - 642

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 3

ER -